Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 4, 1997, Pages 795-801

  Gavaldà, Joan ^a,c   Capdevila, Josep A ^a   Almirante, Benito ^a   Otero, Jordi ^a   Ruiz, Isabel ^a   Laguarda, Montserrat ^a   Allende, Helena ^b   Crespo, Ernesto ^b   Pigrau, Carles ^a   Pahissa, Albert ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFPIROME; PENICILLIN G; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PNEUMONIA; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENCY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8244252280     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.4.795     Document Type: Article

References (44)

1. Anhalt, J. P., and J. A. Washington II. 1985. Bactericidal tests, p. 731-745. In J. A. Washington II (ed.), Laboratory procedures in clinical microbiology. Springer-Verlag, New York, N.Y.
2. Anhalt, J. P. 1985. Antimicrobial assays, p. 691-729. In J. A. Washington II (ed.), Laboratory procedures in clinical microbiology. Springer-Verlag, New York, N.Y.
3. Appelbaum, P. C., A. Bhamjee, J. N. Scragg, A. F. Hallett, A. J. Bowen, and R. C. Cooper. 1977. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet ii:995-997.
4. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
5. Azoulay-Dupuis, E., J. P. Bedos, E. Vallee, D. J. Hardy, R. N. Swanson, and J. J. Pocidalo. 1991. Antipneumococcal activity of ciprofloxacin, ofloxacin, and lemafloxacin in an experimental mouse pneumonia model at various stages of the disease. J. Infect. Dis. 163:319-324.
6. Azoulay-Dupuis, E., E. Vallee, B. Veber, J. P. Bedos, J. Bauchet, and J. J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
7. Bakker-Woudenberg, I. J. A. M., J. C. van den Berg, P. Fontijne, and M. F. Michel. 1984. Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodencient rats. Eur. J. Clin. Microbiol. 3:131-135.
8. Baquero, F., J. Martinez-Beltran, and E. Loza. 1991. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J. Antimicrob. Chemother. 28(Suppl. C).
9. Barry, A. L., S. D. Brown, and W. J. Novick. 1995. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates. Antimicrob. Agents Chemother. 39:2193-2196.
10. Bedos, J. P., O. Rolin, D. H. Bouanchaud, and J. J. Pocidalo. 1991. Relation entre virulence et resistance aux antibiotiques des pneumocoques. Apport des donnees experimentales sur un modele animal. Pathol. Biol. 39:984-990.
11. Blatter, M., U. Fluckinger, J. Entenza, M. P. Glauser, and P. Francioli. 1993. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 31:971-976.
12. Brelman, R. F., J. C. Butier, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
13. Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
14. Donowitz, G. R., and G. L. Mandell. 1994. Acute pneumonia, p. 619-037. In G. E. Mandell, R. G. Douglas, and J. E. Bennet (ed.). Principles and practice of infectious diseases, 4th ed. Churchill Livingstone Inc., New York, N.Y.
15. Fantin, B., J. Leggett, S. Ebert, and W. A. Craig. 1991. Correlation between in vitro and in vivo activity of antimicrobial agents against gram-negative bacilli in a murine infection model. Antimicrob. Agents Chemother. 35: 1413-1422.
16. Feldman, C., J. M. Kallenbach, D. D. Miller, J. R. Thorburn, and H. J. Koornhof. 1985. Community-acquired pneumonia due to penicillin-resistant pneumococci. N. Engl. J. Med. 313:615-617.
17. Fenoll, A., C. Martín-Bourgon, R. Muñoz, D. Vicioso, and J. Casal. 1991. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain. 1979-1989. Rev. Infect. Dis. 13:56-60.
18. Fernander-Guerrero, M. L., F. Arbol, C. Verdejo, R. Fernández-Roblas, and F. Soriano. 1994. Treatment of experimental endocarditis due to penicillin resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 38:1103-1106.
19. Kriedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
20. Friedland, I. R., M. Paris, S. Ehrett, S. Hickley, K. Olsen, and G. H. McCracken, Jr. 1993. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 37:1630-1636.
21. Frimodt-Moller, N., M. W. Bentzon, and V. F. Thomsen. 1986. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J. Infect. Dis. 154:511-517.
22. Frimodt-Moller, N., M. W. Bentzon, and V. F. Thomsen. 1987. Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 95:261-267.
23. Gavaldà, J., P. J. Cardona, J. A. Capdevila, M. Laguarda, B. Almirante, C. Pigrau, E. Crespo, and A. Pahissa. 1996. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother. 40:173-178.
24. Gavaldà, J., M. Laguarda, J. A. Capdevila, L. Pou, E. Crespo, and A. Pahissa. 1995. Ceftriaxone (Cr) plus Gentamicin (G) once-a-day for treatment (Rx) of Staphylocuccus aureus experimental endocarditis, abstr. B44, p. 33. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
25. Gavaldà, J., M. Laguarda, J. A. Capdevila, L. Pou, E. Crespo, B. Almirante, and A. Pahissa. 1995. Treatment of experimental pneumonia (EP) in immunocompetent rats due to penicillin-resistant Streptococcus pneumoniae (PRSP), abstr. A90. p. 17. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Gerber, A. U., H. P. Brugger, Ch. Feller, T. Stritzko, and B. Stalder. 1986. Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. J. Infect. Dis. 153:90-97.
27. Gerber, A. U., T. Stritzko, C. Segessenmann, and B. Stalder. 1991. Simulation of human pharmacokinetics profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia model. Scand. J. Infect. Dis. 74:195-230.
28. Hansman, D., H. Glasgow, J. Sturt, L. Devilt, and R. Douglas. 1971. Increased resistance to penicillin of pneumococci isolated from man. N. Engl. J. Med. 284:175-177.
29. Jacobs, M. R., H. J. Kooornhof, R. M. Robins-Browne, R. M. Stevenson, Z. A. Vermaak, I. Freiman, G. B. Miller, M. A. Whitcoínb, M. Isaacson, J. I. Ward, and R. Austrian. 1978. Emergence of multiply-resistant pneumococci. N. Engl. J. Med. 299:735-740.
30. Knudsen, J. D., N. Fridmodt-Moller, and F. Espersen. 1995. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin. Antimicroh. Agents Chemother. 39:1253-1258.
31. Liñares, J., R. Pallarés, T. Alonso, J. L. Pérez, J. Ayats, F. Gudiol, P. F. Viladrich, and R. Martin. 1992. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin. Infect. Dis. 15:99-105.
32. Liñares, J., T. Alonso, J. L. Pere, J. Ayats, M. A. Dominguez, R. Pallares, and R. Martin. 1992. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J. Antimicrob. Chemother. 30:279-288.
33. Magnusson, V., H. Erlendsdottir, S. Kristinsson, and S. Gudmundsson. 1995. Comparative efficacy of penicillin and ceftriaxone against penicillin resistant pneumococci in a mouse pneumonia model, abstr. A89, p. 17. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
34. Maestro, T. D., A. Ghafoor, N. K. Nomani, Z. Ishaq, F. Anwar, D. M. Granoff, J. S. Spika, C. Thornsberry, and R. R. Facklam. 1991. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 337:156-159.
35. Marton, A., M. Guiyas, R. Muñoz, and A. Tomasz. 1991. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J. Infect. Dis. 163:542-548.
36. Moine, P., E. Vallee, E. Azoulay-Dupuis, J. P. Bedos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
37. Munoz, R., J. M. Musser, M. Crain, D. E. Briles, A. Marton, A. J. Parkinson, U. Sorensen, and A. Tomasz. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and rnultifocus enzyme analysis. Clin. Infect. Dis. 15:112-118.
38. Pallares, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
39. Pennington, J. E., and R. M. Stone. 1979. Comparison of antibiotic regimens for treatment of experimental pneumonia due to pseudomonas. J. Infect. Dis. 140:881-889.
40. Powell, M., D. McVey, M. H. Kassim, H. Y. Chen, and J. D. Williams. 1991. Antimicrobial susceptibility of Streptococcus pneumonia, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J. Antimicrob. Chemother. 28:249-259.
41. Privitera, G. 1994. Penicillin resistance among Streptococcus pneumoniae in Europe. Diagn. Microbiol. Infect. Dis. 19:157-161.
42. Sacho, H., K. P. Kiugman, H. J. Koornhof, and P. Ruff. 1987. Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus. J. Infect. 14:1824-1827.
43. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob. Agents Chemother. 38:898-900.
44. Tateda, K., K. Tajkashima, H. Miyazaki, T. Matsumoto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model, Antimicrob. Agents Chemother. 40:1520-1525.